Biocodex, Inc. is the U.S. subsidiary of Biocodex, a family-owned international pharmaceuticals company founded in France in 1953. At Biocodex, we listen to the needs of patients, caregivers, and healthcare professionals to develop innovative products and solutions to help ease the burden of rare diseases. As the makers of DIACOMIT® (stiripentol), we are dedicated to advancing scientific research and using our expertise to benefit the rare disease community.